Quick answers
- What is Ergocalciferol used for?
- The FDA-approved label (Ergocalciferol, Torrent Pharmaceuticals Limited, September 4, 2026) says: “Ergocalciferol is indicated for use in the treatment of hypoparathyroidism, refractory rickets, also known as vitamin D resistant rickets, and familial hypophosphatemia.” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
- Does Ergocalciferol have a boxed warning?
- No. None of the 35 FDA labels we found for this medicine has a boxed warning.
- Is there a shortage of Ergocalciferol?
- No current shortage is listed by the FDA for the products of this medicine (FDA data from October 30, 2026).
- Has Ergocalciferol been recalled?
- No recall linked to the products of this medicine appears in the FDA enforcement reports we use.
- Who makes Ergocalciferol?
- 20 companies list prescription products of Ergocalciferol in the FDA NDC Directory, including Bryant Ranch Prepack, Aphena Pharma Solutions - Tennessee, LLC and Remedyrepack Inc..
What Ergocalciferol is used for
Quoted from the “Indications and Usage” section of the FDA-approved label.
Ergocalciferol is indicated for use in the treatment of hypoparathyroidism, refractory rickets, also known as vitamin D resistant rickets, and familial hypophosphatemia.
— FDA label: Ergocalciferol, Torrent Pharmaceuticals Limited, effective September 4, 2026. Read the full label on DailyMed →
The FDA has 35 labels for products of this medicine (different makers and forms); uses can differ between them. Check the label that comes with your own medicine.
This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Boxed warning
A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.
The label quoted above has no boxed warning.
0 of 35 FDA labels for this medicine have a boxed warning.
Forms and how it is given
| Dosage forms | Capsule · Capsule, liquid filled |
|---|---|
| Route | Oral |
| Prescription products | 38 in the FDA NDC Directory |
| Brand names | Vitamin D |
What pharmacies pay (NADAC)
The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.
This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.
| Strength and form | Generic or brand | Pharmacies pay |
|---|---|---|
| ergocalciferol 1.25 mg capsule | Generic | $0.1162 per capsule |
| ergocalciferol 1.25 mg capsule, liquid filled | Generic | $0.1162 per capsule |
NADAC list of November 4, 2026; these prices took effect on October 21, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.
Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →
Companies that list this medicine
Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.
- Bryant Ranch Prepack8 products
- Aphena Pharma Solutions - Tennessee, LLC4 products
- Remedyrepack Inc.3 products
- Preferred Pharmaceuticals Inc.3 products
- Proficient Rx LP2 products
- NuCare Pharmaceuticals, Inc.2 products
- PD-Rx Pharmaceuticals, Inc.2 products
- Northwind Health Company, LLC2 products
- A-S Medication Solutions1 product
- Bionpharma Inc.1 product
- Chartwell RX, LLC1 product
- Strides Pharma Science Limited1 product
- AvKARE1 product
- St. Mary's Medical Park Pharmacy1 product
- Epic Pharma, LLC1 product
- Advanced Rx Pharmacy of Tennessee, LLC1 product
- AvPAK1 product
- Torrent Pharmaceuticals Limited1 product
- Golden State Medical Supply, Inc.1 product
- DirectRx1 product
FDA approval history
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Application | Sponsor | Approved | Later changes approved |
|---|---|---|---|
| NDA003444 DRISDOL | Esjay Pharma | January 11, 1941 | 14, latest November 20, 2003 2003: Labeling · 1992: Manufacturing (CMC) · 1990: Manufacturing (CMC) |
Generic approvals (4)
- ANDA080704Bionpharma · October 16, 1978
- ANDA040833Chartwell Rx · May 20, 2009
- ANDA090455Onesource · August 3, 2010
- ANDA204276Puracap Pharm LLC · December 7, 2018
Shortage status
The FDA drug shortage list does not show these products.
Recalls
No recall linked to these products (by their NDC code) appears in the FDA enforcement reports.
Official identifiers
| RxCUI (RxNorm) | 1367410 |
|---|---|
| SPL set ID of the quoted label | 4ae38744-020d-4c37-a6f1-88f55c2f1047 |
| FDA labels (SPL) | 35 |
| FDA applications | NDA003444, 4 ANDA |
| Active ingredients (FDA) | ERGOCALCIFEROL |
Sources
- FDA-approved label on DailyMed (National Library of Medicine) — Ergocalciferol, Torrent Pharmaceuticals Limited, effective September 4, 2026; via openFDA, FDA data exported October 30, 2026, retrieved October 31, 2026
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →